Interest Paid, Excluding Capitalized Interest, Operating Activities of ENANTA PHARMACEUTICALS INC from 30 Sep 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
ENANTA PHARMACEUTICALS INC quarterly and annual Interest Paid, Excluding Capitalized Interest, Operating Activities in USD history and change rate from 30 Sep 2011 to 31 Dec 2025.
  • ENANTA PHARMACEUTICALS INC Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 31 Dec 2025 was $2,379,000, a 21% decline year-over-year.
  • ENANTA PHARMACEUTICALS INC annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2025 was $8,794,000, a 25% decline from 2024.
  • ENANTA PHARMACEUTICALS INC annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $11,710,000, a 489% increase from 2023.
  • ENANTA PHARMACEUTICALS INC annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $1,987,000.
Source SEC data
View on sec.gov
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Change (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Change (%)

ENANTA PHARMACEUTICALS INC Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,379,000 -$629,000 -21% 01 Oct 2025 31 Dec 2025 10-Q 11 Feb 2026 2026 Q1
Q4 2024 $3,008,000 -$135,000 -4.3% 01 Oct 2024 31 Dec 2024 10-Q 11 Feb 2026 2026 Q1
Q4 2023 $3,143,000 +$3,143,000 01 Oct 2023 31 Dec 2023 10-Q 12 Feb 2025 2024 Q1
Q4 2022 $0 01 Oct 2022 31 Dec 2022 10-Q 08 Feb 2024 2024 Q1

ENANTA PHARMACEUTICALS INC Annual Interest Paid, Excluding Capitalized Interest, Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $8,794,000 -$2,916,000 -25% 01 Oct 2024 30 Sep 2025 10-K 19 Nov 2025 2025 FY
2024 $11,710,000 +$9,723,000 +489% 01 Oct 2023 30 Sep 2024 10-K 19 Nov 2025 2025 FY
2023 $1,987,000 +$1,987,000 01 Oct 2022 30 Sep 2023 10-K 19 Nov 2025 2025 FY
2022 $0 01 Oct 2021 30 Sep 2022 10-K 27 Nov 2024 2024 FY
2011 $1,056,000 01 Oct 2010 30 Sep 2011 10-K 18 Dec 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.